Liver cancer
Conditions
Interventions
Cavitation treatment group:None
Control group:None
Sponsors
Affiliated Hospital of Guangdong Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Age between 18~75 years old; 2. Measurable and evaluable tumor lesions on images; 3. Patients who have been clinically recognized as feasible with transarterial intervention combined with target immunity; 4. No serious damage to liver, heart, brain, kidneys and other important organs 5. Physical condition is <=2 with ECOG (Eastern Cooperative Oncology Group) score; 6. Sign the informed consent form and have good compliance, with complete medical records and imaging data.
Exclusion criteria
Exclusion criteria: 1. Combined with organic changes of important organs such as heart, brain, kidney, etc., or accompanied by other malignant tumors; 2. Allergy to chemotherapy drugs or ultrasound contrast media and hypersensitivity; 3. Patients with incomplete clinical data and imaging data; 4. Patients with poor follow-up compliance.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 2-year objective response rate ORR between treatment and control groups; | — |
Secondary
| Measure | Time frame |
|---|---|
| Overall Survival OS;Contrast-enhanced ultrasound parameters;Serum tumor marker;Adverse reaction;Disease control rate DCR;Duration of response DOR;Objective response rate (ORR).;Progression-free survival PFS; | — |
Countries
China
Contacts
Public ContactXu Xiaohong
Affiliated Hospital of Guangdong Medical University
Outcome results
None listed